Imaging Technique May Trace Development of Parkinson’s Disease
University of Illinois at Chicago Office of Public Affairs, by Paul Francuch, March 24, 2009
While finding a biomarker for Parkinson’s disease that would let physicians screen for or track its progression remains an elusive goal, a team led by a University of Illinois at Chicago neuroscientist has shown that a non-invasive brain scanning technique offers promise.
Experimental Parkinson’s therapy may have robust weight-loss effect
University of Florida News, Filed under Health, Research on Tuesday, March 24, 2009
A growth factor used in clinical experiments to rescue dying brain cells in Parkinson patients may cause unwanted weight loss if delivered to specific areas of the brain, according to University of Florida researchers in the March online edition of Molecular Therapy.
Novel spinal cord stimulator sparks hope for Parkinson’s disease treatment
PhysOrg, March 19th, 2009
A novel stimulation method, the first potential therapy to target the spinal cord instead of the brain, may offer an effective and less invasive approach for Parkinson’s disease tre
Stanford study improves insights into Parkinson’s disease and possible treatments
EurekAlert!, by David Orenstein, Public release date: 19-Mar-2009
About the only thing doctors have understood about deep-brain stimulation, which is widely used to treat Parkinson’s disease symptoms, is that somehow it works for many patients. In a new study that will be published March 19 in the online journal Science Express, Stanford University researchers used light to illuminate how the treatment works, generating surprising insights into the diseased circuitry and also suggesting new ideas to improve Parkinson’s therapy.
Sensors For Use In Parkinson’s Disease Control
Medical News Today, Article Date: 18 Mar 2009 – 2:00 PDT
Companies and organizations from the fields of ICTs, computing, drug engineering and health have joined forces under the joint research project Home-based Empowered Living for Parkinson’s Disease (HELP)…
Renowned Stem Cell Researcher Files Study Results With Stemedica
PR Web, March 18, 2009
Stemedica Cell Technologies, Inc., (“Stemedica”), a leader in adult stem cell research and manufacturing, received the results today from a Stemedica-sponsored clinical study conducted by renowned stem cell researcher and clinician Professor Philippe Hernigou, MD, Ph.D. The approved clinical study featured Dr. Hernigou’s treatment of non-union bone injuries using autologous stem cells, allogeneic stem cells and comparative traditional treatment therapies.
Dance By Protein Linked To Parkinson’s And Alzheimer’s Diseases Reveals Unprecedented Twists And Turns
Medical News Today, Article Date: 18 Mar 2009 – 0:00 PDT
In an Early Edition publication of The Proceedings of the National Academy of Sciences (PNAS) this week, the researchers demonstrate the “alpha-synuclein dance” – the switching back and forth of the protein between a bent helix and an extended helix as the surface that it is binding to changes.
Neuroscientists fear brain drain as crucial funding disappears
The Globe & Mail, ANNE MCILROY, SCIENCE REPORTER, March 11, 2009
Two years ago, a team of Canadian neuroscientists investigating the roots of Parkinson’s disease, attention deficit disorder and other conditions came up with a plan to bullet-proof their research labs from a devastating drop in funding.
Addiction: Insights From Parkinson’s Disease
ScienceDaily (Mar. 3, 2009)
A new comprehensive review by researchers at the Montreal Neurological Institute (MNI), McGill University and the University of Cambridge, England provides vital insights into the neurological basis of addiction by investigating Parkinson’s disease patients, who in some instances develop various addictions when undergoing medical treatment.
ProteoTech Receives Funding From The Michael J. Fox Foundation for Parkinson’s Disease Research to Develop Tools for Imaging Alpha-Synuclein Aggregation in Living Parkinson’s Brain
Yahoo Finance!, Monday March 2, 2009, 5:38 pm EST
KIRKLAND, Wash., Feb 26 /PRNewswire/ — ProteoTech Inc. announced today that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Disease Research. In collaboration with Avid Radiopharmaceuticals Inc. (Philadelphia, PA), ProteoTech scientists will utilize ProteoTech’s small molecule platform drug technology to develop new imaging agents that will allow doctors to use PET imaging to identify and determine the extent of alpha-synuclein accumulation in the living human brain.
Improving Understanding Of Parkinson’s Disease With The Help Of Yeast
Medical News Today, Article Date: 02 Mar 2009 – 1:00 PST
Teams of scientists from Australia and the United States have used yeast and mammalian cells to discover a connection between genetic and environmental causes of Parkinson’s disease. Yeasts are single cell organisms, used widely in biological research because their structure resembles that of cells found in animals and humans. Yeasts share many genes, or their functional equivalents, with humans and offer the ability to screen or test thousands of genes and analysing their effects.
How yeast is helping us to understand Parkinson’s Disease
EurekAlert!, Public release date: 27-Feb-2009
Teams of scientists from Australia and the United States have used yeast and mammalian cells to discover a connection between genetic and environmental causes of Parkinson’s disease. Yeasts are single cell organisms, used widely in biological research because their structure resembles that of cells found in animals and humans. Yeasts share many genes, or their functional equivalents, with humans and offer the ability to screen or test thousands of genes and analysing their effects.
Technology Brings Us Closer To Early Diagnosis Of Parkinson’s Disease
Medical News Today / Article Date: 16 Feb 2009 – 2:00 PST
It is estimated that 4 million people world-wide are suffering from Parkinson’s, a complex disease that varies greatly among affected individuals. Understanding the brain chemistry that leads to the onset of Parkinson’s is vital if we are to develop methods for early MRI diagnosis and new treatments for this devastating disease. Speaking at the AAAS Meeting in Chicago, Dr Joanna Collingwood, from Keele University, presented new results from studies carried out, in collaboration with Dr Mark Davidson from the University of Florida (UF), at Diamond – the UK’s national synchrotron.
Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinson’s Disease
Yahoo Finance / Monday February 16, 2009, 9:11 am EST
LOS ANGELES, Feb. 16 /PRNewswire/ — Scientists announced today the publication of a landmark peer-reviewed paper in the February issue of the Bentham Open Stem Cell Journal which outlines the long term results of the world’s first clinical trial using autologous neural stem cells for the treatment of Parkinson’s disease. According to lead author, Michel F. Levesque, MD, FRCS©, FACS, “We have documented the first successful adult neural stem cell transplantation to reverse the effects of Parkinson’s disease and demonstrated the long term safety and therapeutic effects of this approach.” Dr Levesque is a principal investigator for NeuroGeneration, a biotechnology company, and is affiliated with the UCLA School of Medicine and the Brain Research Institute.<.p>
X-ray eyes bring us closer to early diagnosis of Parkinson’s disease
Phys.Org / February 14th, 2009 in Medicine Health / Diseases
It is estimated that 4 million people world-wide are suffering from Parkinson’s, a complex disease that varies greatly among affected individuals. Understanding the brain chemistry that leads to the onset of Parkinson’s is vital if we are to develop methods for early MRI diagnosis and new treatments for this devastating disease. Speaking at the AAAS Meeting in Chicago, Dr Joanna Collingwood, from Keele University, will present new results from studies carried out, in collaboration with Dr Mark Davidson from the University of Florida (UF), at Diamond – the UK’s national synchrotron.
Senator seeks way around state’s embryonic stem-cell research ban
Capital Journal, South Dakota / Published/Last Modified on Friday, Feb 13, 2009 – 06:05:27 am CST Bob Mercer
PIERRE — The sponsor of legislation that attempts to totally repeal South Dakota’s ban against using human embryos for stem-cell research said Thursday he didn’t intend to leave the practice totally unrestricted. Sen. Ben Nesselhuf, D-Vermillion, said he now wants to rewrite the measure so that research could be conducted using only the 21 existing stem-cell lines that are eligible for federal research aid under President Bush’s 2001 directive. South Dakota’s ban has been in effect since 2000.
Intense light ‘could detect Parkinson’s’
A light as bright as a million-watt bulb could help detect the early stages of Parkinson’s Disease, according to scientists.
Telegraph.co.uk / Last Updated: 2:51PM GMT 14 Feb 2009
A team from Keele University, in Staffordshire, are using a “super-microscope” to spot changes in brain cells before the disease destroys them. Dr Joanna Collingwood, told the American Association for the Advancement of Science conference in Chicago, that the technique could allow patients to receive treatment sooner.
Read more…, Also see BBC News / Light ‘could detect Parkinson’s’
X-ray eyes bring us closer to early diagnosis of Parkinson’s disease
EurekAlert / Public release date: 13-Feb-2009
It is estimated that 4 million people world-wide are suffering from Parkinson’s, a complex disease that varies greatly among affected individuals. Understanding the brain chemistry that leads to the onset of Parkinson’s is vital if we are to develop methods for early MRI diagnosis and new treatments for this devastating disease. Speaking at the AAAS Meeting in Chicago, Dr Joanna Collingwood, from Keele University, will present new results from studies carried out, in collaboration with Dr Mark Davidson from the University of Florida (UF), at Diamond – the UK’s national synchrotron. Their results show that the distribution of metal ions in the brain tissue of sufferers is altered by the disease process.
UAB research team connects welding fumes to Parkinson’s disease
by DAVE PARKS News staff write, The Birmingham Times
Monday, February 09, 2009
A study of Alabama welders in 2005 confirmed what scientists have known for decades: Sufficient exposure to manganese, a metal often found in welding fumes, can cause the debilitating symptoms of Parkinson’s disease – tremors, loss of movement, stiffness and imbalance.
Obama Yet To Lift Restrictions On Embryonic Stem Cell Research
Medical News Today, Article Date: 05 Feb 2009 – 4:00 PST
Proponents of embryonic stem cell research continue to await President Obama’s expected executive order to lift former President George W. Bush’s restrictions on federal funding for research on embryonic stem cell lines created after August 2001, the Philadelphia Inquirer reports.
-
Archives
- March 2009 (176)
- February 2009 (115)
-
Categories
- 18162508
- Anti-Depressant
- Bio Tech Industry
- Caregiver
- Clinical Trials
- Coffee
- Depression
- Documentary
- Electronic Medcial Records
- EMEA
- Environmental Causes
- Ethics
- European Medicines Agency
- FDA
- Generic Drugs
- Genetic Mutation
- Genetics
- Health and Human Services Dept
- Healthcare Reform
- HHS
- IRB
- Law
- Legislation
- Lobbying
- Medical Devices
- Medicare
- Mental Health
- MJ Fox
- Neurotoxins
- NHS (United Kingdom)
- NIH
- NIH Funding
- Obama Administration
- Orphan Drugs
- Other Research
- Parkinson's related video
- PD Cause
- PD Clinical Trials
- PD Medical Clinics
- PD Personal Stories
- PD Prevention Research
- PD Research
- PD Support Group News
- PD Surgery
- PD Therapies
- Pharmaceutical Industry
- Prescription Drugs
- PWP In The News
- Religion
- Research with potential for PD
- Social Security
- Social Web Sites
- Stimulus Package
- Stress Effect
- Uncategorized
- YouTube
-
RSS
Entries RSS
Comments RSS
PWP News 